Anxiety State: Clinical Trials

4 trials for Anxiety State, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated, 1 unknown. 4 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 2, Terminated 1, Unknown 1
Phase 22Completed 2

Follow Anxiety State: new trials by email Literature Review of Anxiety State trials Research Report on Anxiety State

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
a Phase III Trial of Safety and Efficacy of Premedication With Dexmedetomidine and Midazolam in Pediatric Patients
Midazolam, Dexmedetomidine, Placebo - Anxiety State, Perioperative/Postoperative Complications
Phase 3UnknownKing Faisal Specialist Hospital & Research Center802021-10-172023-11-24
Substance Misuse To Psychiatric Disorders for Cannabis
Vortioxetine, Treatment as Usual - Cannabis Use Disorder, Depressive State
Phase 2 / Phase 3CompletedThe University of Hong Kong372018-07-252023-07-05
Is Initial Response to Low Dose Risperidone Predictive for Outcome in Anxiety?
RisperiDONE 0.5 MG - Anxiety State
Phase 3TerminatedMarion Trousselard1202017-09-012022-08-04
Anxiety Assessment Intervention in Dental Patients
Information to health provider without patient knowledge, dentist behaviour and patient expectancy - Anxiety State
Phase 2 / Phase 3CompletedUniversity of St Andrews1822003-09-012010-08-30

Narrower conditions

Anxiety Disorders (4)  ·  Depression (1)  ·  Marijuana Abuse (1)  ·  Postoperative Complications (1)

Broader conditions

Mental Disorders (4)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Chemically-Induced Disorders (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Substance-Related Disorders (1)

Interventions

Dexmedetomidine (1)  ·  Midazolam (1)  ·  Risperidone (1)  ·  Therapeutics (1)  ·  Vortioxetine (1)

Sponsors

King Faisal Specialist Hospital & Research Center (1)  ·  Marion Trousselard (1)  ·  The University of Hong Kong (1)  ·  University of St Andrews (1)

Countries

France (1)  ·  Hong Kong (1)  ·  Saudi Arabia (1)  ·  United Kingdom (1)

Top investigators

Albert KK Chung, MBBS(HK) (1)  ·  Bertrand Lahutte (1)  ·  Ganesh Sivasankara, MBBS (1)  ·  Gerald M Humphris, PhD (1)

NIH funding

2016 (1)